Cardiovascular Events Associated With Ipratropium Bromide in COPD

Chest - Tập 137 - Trang 13-19 - 2010
Sarika S. Ogale1, Todd A. Lee2,3, David H. Au4, Denise M. Boudreau1,5, Sean D. Sullivan1
1Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA
2Center for Management of Complex Chronic Care, Hines VA Hospital, Hines, IL
3Center for Pharmacoeconomic Research and Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
4Health Services Research and Development, VA Puget Sound Health Care System and Department of Medicine, University of Washington, Seattle, WA
5The Center for Health Studies, Group Health Cooperative, Seattle, WA

Tài liệu tham khảo

Barnes, 2004, The role of anticholinergics in chronic obstructive pulmonary disease, Am J Med, 117, 24S Tashkin, 2008, A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, 359, 1543, 10.1056/NEJMoa0805800 Anthonisen, 2002, Hospitalizations and mortality in the Lung Health Study, Am J Respir Crit Care Med, 166, 333, 10.1164/rccm.2110093 Guite, 1999, Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma, Thorax, 54, 301, 10.1136/thx.54.4.301 Lee, 2008, Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease, Ann Intern Med, 149, 380, 10.7326/0003-4819-149-6-200809160-00004 Macie, 2008, Cardiovascular morbidity and the use of inhaled bronchodilators, Int J Chron Obstruct Pulmon Dis, 3, 163 Singh, 2008, Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis, JAMA, 300, 1439, 10.1001/jama.300.12.1439 Fan, 2003, Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis, Am J Respir Crit Care Med, 168, 1488, 10.1164/rccm.200301-019OC Lee, 2006, Spirometry use in clinical practice following diagnosis of COPD, Chest, 129, 1509, 10.1378/chest.129.6.1509 Donaldson, 2006, COPD exacerbations. 1: Epidemiology, Thorax, 61, 164, 10.1136/thx.2005.041806 Fisher, 1999, Time-dependent covariates in the Cox proportional-hazards regression model, Annu Rev Public Health, 20, 145, 10.1146/annurev.publhealth.20.1.145 Ringbaek, 2003, Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?, Respir Med, 97, 264, 10.1053/rmed.2003.1423 Salpeter, 2006, Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD, J Gen Intern Med, 21, 1011, 10.1111/j.1525-1497.2006.00507.x Hynes, 2007, Veterans' access to and use of Medicare and Veterans Affairs health care, Med Care, 45, 214, 10.1097/01.mlr.0000244657.90074.b7